Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase'
(id=8087779 ; fe=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=6682 creation date=2017-07-21 touchdate=2024-11-19 21:53:40.000)
≈ 222 relations sortantes

  1. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 43 / 1 -> en:circulating tumor cell test
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:circulating tumor cell test | rel=r_associated | relid=0 | w=43
  2. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 42 / 0.977 -> en:documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation) | rel=r_associated | relid=0 | w=42
  3. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 41 / 0.953 -> en:clinician documented that patient recevied vascular access other than autogenous av fistula, reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:clinician documented that patient recevied vascular access other than autogenous av fistula, reason not given | rel=r_associated | relid=0 | w=41
  4. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 39 / 0.907 -> en:complete gene sequence analysis; msh2 gene
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:complete gene sequence analysis; msh2 gene | rel=r_associated | relid=0 | w=39
  5. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 38 / 0.884 -> en:abdominal aortic aneurysm is not infarenal
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:abdominal aortic aneurysm is not infarenal | rel=r_associated | relid=0 | w=38
  6. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 36 / 0.837 -> en:chlorpromazine hydrochloride, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:chlorpromazine hydrochloride, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | rel=r_associated | relid=0 | w=36
  7. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 35 / 0.814 -> en:12-lead electrocardiogram (ecg) performed
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:12-lead electrocardiogram (ecg) performed | rel=r_associated | relid=0 | w=35
  8. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 35 / 0.814 -> en:adenoma(s) or other neoplasm not detected during screening colonoscopy
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:adenoma(s) or other neoplasm not detected during screening colonoscopy | rel=r_associated | relid=0 | w=35
  9. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 35 / 0.814 -> en:all quality actions for the applicable measures in the cardiovascular prevention measures group have bee performed for this patient
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:all quality actions for the applicable measures in the cardiovascular prevention measures group have bee performed for this patient | rel=r_associated | relid=0 | w=35
  10. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 35 / 0.814 -> en:all quality actions for the applicable measures in the ischemic vascular disease (ivd) measures group have been performed for this patient
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:all quality actions for the applicable measures in the ischemic vascular disease (ivd) measures group have been performed for this patient | rel=r_associated | relid=0 | w=35
  11. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 35 / 0.814 -> en:assessment of depression severity at the initial evaluation
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:assessment of depression severity at the initial evaluation | rel=r_associated | relid=0 | w=35
  12. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 35 / 0.814 -> en:clinician documented that patient was not an eligible candidate for autogenous av fistula
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:clinician documented that patient was not an eligible candidate for autogenous av fistula | rel=r_associated | relid=0 | w=35
  13. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 35 / 0.814 -> en:complete and appropriate patient data were reported to a qualified clinical database registry
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:complete and appropriate patient data were reported to a qualified clinical database registry | rel=r_associated | relid=0 | w=35
  14. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 35 / 0.814 -> en:complete brca1 and brca2 gene sequence analysis for susceptibility to breast and ovarian cancer
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:complete brca1 and brca2 gene sequence analysis for susceptibility to breast and ovarian cancer | rel=r_associated | relid=0 | w=35
  15. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 35 / 0.814 -> en:compounded drug, not otherwise classified
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:compounded drug, not otherwise classified | rel=r_associated | relid=0 | w=35
  16. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 35 / 0.814 -> en:documentation of patient reason(s) for not being able to assess (e.g., patient refuses endoscopic and/or radiologic assessment)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:documentation of patient reason(s) for not being able to assess (e.g., patient refuses endoscopic and/or radiologic assessment) | rel=r_associated | relid=0 | w=35
  17. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 35 / 0.814 -> en:documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e.g., patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make th
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e.g., patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make th | rel=r_associated | relid=0 | w=35
  18. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 34 / 0.791 -> en:clinician documented that patient is not an eligible candidate for counseling regarding contraception prior to antiviral treatment; patient not receiving antiviral treatment for hepatitis c
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:clinician documented that patient is not an eligible candidate for counseling regarding contraception prior to antiviral treatment; patient not receiving antiviral treatment for hepatitis c | rel=r_associated | relid=0 | w=34
  19. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 34 / 0.791 -> en:death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement period
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement period | rel=r_associated | relid=0 | w=34
  20. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 34 / 0.791 -> en:documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | rel=r_associated | relid=0 | w=34
  21. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 32 / 0.744 -> en:anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies) | rel=r_associated | relid=0 | w=32
  22. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 32 / 0.744 -> en:clinician documented that patient was not an eligible candidate for ordering prophylactic parenteral antibiotics to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incisio
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:clinician documented that patient was not an eligible candidate for ordering prophylactic parenteral antibiotics to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incisio | rel=r_associated | relid=0 | w=32
  23. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 32 / 0.744 -> en:colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique | rel=r_associated | relid=0 | w=32
  24. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 32 / 0.744 -> en:counseling for diet and physical activity performed
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:counseling for diet and physical activity performed | rel=r_associated | relid=0 | w=32
  25. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 31 / 0.721 -> en:aneurysm minor diameter <= 5.5 cm for men
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:aneurysm minor diameter <= 5.5 cm for men | rel=r_associated | relid=0 | w=31
  26. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 31 / 0.721 -> en:ankle orthosis, ankle gauntlet or similar, with or without joints, custom a fabricated
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:ankle orthosis, ankle gauntlet or similar, with or without joints, custom a fabricated | rel=r_associated | relid=0 | w=31
  27. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:aneurysm minor diameter <= 6 cm for men
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:aneurysm minor diameter <= 6 cm for men | rel=r_associated | relid=0 | w=30
  28. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:aneurysm minor diameter >6cm for women
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:aneurysm minor diameter >6cm for women | rel=r_associated | relid=0 | w=30
  29. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:aneurysm minor diameter 5.6-6.0 cm for women
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:aneurysm minor diameter 5.6-6.0 cm for women | rel=r_associated | relid=0 | w=30
  30. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:beta-blocker at discharge
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:beta-blocker at discharge | rel=r_associated | relid=0 | w=30
  31. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:colonoscopy through stoma; with transendoscopic stent placement (includes predilation)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:colonoscopy through stoma; with transendoscopic stent placement (includes predilation) | rel=r_associated | relid=0 | w=30
  32. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:congestive heart failure telemonitoring, equipment rental, including telescale, computer system and software, telephone connections, and maintenance, per month
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:congestive heart failure telemonitoring, equipment rental, including telescale, computer system and software, telephone connections, and maintenance, per month | rel=r_associated | relid=0 | w=30
  33. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet | rel=r_associated | relid=0 | w=30
  34. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:dna analysis of the f5 gene for susceptibility to factor v leiden thrombophilia
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:dna analysis of the f5 gene for susceptibility to factor v leiden thrombophilia | rel=r_associated | relid=0 | w=30
  35. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:documentation of medical reason(s) for not performing serum creatinine test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:documentation of medical reason(s) for not performing serum creatinine test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | rel=r_associated | relid=0 | w=30
  36. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required) | rel=r_associated | relid=0 | w=30
  37. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:electronic wrist rotator, otto bock or equal
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:electronic wrist rotator, otto bock or equal | rel=r_associated | relid=0 | w=30
  38. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:factor ix (antihemophilic factor, recombinant), rixubis, per i.u.
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:factor ix (antihemophilic factor, recombinant), rixubis, per i.u. | rel=r_associated | relid=0 | w=30
  39. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:genetic testing for canavan disease
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:genetic testing for canavan disease | rel=r_associated | relid=0 | w=30
  40. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:injection, asparaginase erwinia chrysanthemi, 1,000 international units (i.u.)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, asparaginase erwinia chrysanthemi, 1,000 international units (i.u.) | rel=r_associated | relid=0 | w=30
  41. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:injection, human fibrinogen concentrate, 100 mg
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, human fibrinogen concentrate, 100 mg | rel=r_associated | relid=0 | w=30
  42. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:injection, taliglucerase alfa, 10 units
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, taliglucerase alfa, 10 units | rel=r_associated | relid=0 | w=30
  43. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:injection, testosterone enanthate, up to 200 mg administered
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, testosterone enanthate, up to 200 mg administered | rel=r_associated | relid=0 | w=30
  44. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:injection, ziv-aflibercept, 1 mg
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, ziv-aflibercept, 1 mg | rel=r_associated | relid=0 | w=30
  45. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:injection, zoledronic acid (zometa), 1 mg administered
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, zoledronic acid (zometa), 1 mg administered | rel=r_associated | relid=0 | w=30
  46. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band) | rel=r_associated | relid=0 | w=30
  47. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:most recent ldl-c under control, results documented and reviewed
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:most recent ldl-c under control, results documented and reviewed | rel=r_associated | relid=0 | w=30
  48. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:netupitant 300 mg and palonosetron 0.5 mg
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:netupitant 300 mg and palonosetron 0.5 mg | rel=r_associated | relid=0 | w=30
  49. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:patch closure used for patient undergoing conventional cea
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patch closure used for patient undergoing conventional cea | rel=r_associated | relid=0 | w=30
  50. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:patient treated for spoken language expression but not scored on the spoken language expression functional communication measure either at admission or at discharge
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient treated for spoken language expression but not scored on the spoken language expression functional communication measure either at admission or at discharge | rel=r_associated | relid=0 | w=30
  51. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | rel=r_associated | relid=0 | w=30
  52. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:prostate cancer antigen 3 (pca3) testing
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:prostate cancer antigen 3 (pca3) testing | rel=r_associated | relid=0 | w=30
  53. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 30 / 0.698 -> en:score on the motor speech functional communication measure at discharge was higher than at admission
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:score on the motor speech functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=30
  54. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed for patients with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic fun
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed for patients with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic fun | rel=r_associated | relid=0 | w=29
  55. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:automated eeg monitoring
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:automated eeg monitoring | rel=r_associated | relid=0 | w=29
  56. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:beta blocker contraindicated
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:beta blocker contraindicated | rel=r_associated | relid=0 | w=29
  57. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:clinician documented that patient with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function was not an eligible candidate for angiotensin converting enzyme (ace) inhibi
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:clinician documented that patient with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function was not an eligible candidate for angiotensin converting enzyme (ace) inhibi | rel=r_associated | relid=0 | w=29
  58. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:complete apc gene sequence analysis for susceptibility to familial adenomatous polyposis (fap) and attenuated fap
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:complete apc gene sequence analysis for susceptibility to familial adenomatous polyposis (fap) and attenuated fap | rel=r_associated | relid=0 | w=29
  59. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | rel=r_associated | relid=0 | w=29
  60. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:diabetes screening test not performed, reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:diabetes screening test not performed, reason not given | rel=r_associated | relid=0 | w=29
  61. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | rel=r_associated | relid=0 | w=29
  62. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:injection, epoetin alfa, 1000 units (for esrd on dialysis) administered
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, epoetin alfa, 1000 units (for esrd on dialysis) administered | rel=r_associated | relid=0 | w=29
  63. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:injection, morphine sulfate, 100mg
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, morphine sulfate, 100mg | rel=r_associated | relid=0 | w=29
  64. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:levonorgestrel 52mg intrauterine system
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:levonorgestrel 52mg intrauterine system | rel=r_associated | relid=0 | w=29
  65. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:miscellaneous supply or accessory for use with ventricular assist device
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:miscellaneous supply or accessory for use with ventricular assist device | rel=r_associated | relid=0 | w=29
  66. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:most recent ldl-c not under control, results documented and reviewed
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:most recent ldl-c not under control, results documented and reviewed | rel=r_associated | relid=0 | w=29
  67. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:no anti-lipid treatment at discharge
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:no anti-lipid treatment at discharge | rel=r_associated | relid=0 | w=29
  68. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:patient not treated for attention disorder
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient not treated for attention disorder | rel=r_associated | relid=0 | w=29
  69. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | rel=r_associated | relid=0 | w=29
  70. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:prednisone, oral, per 5 mg
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:prednisone, oral, per 5 mg | rel=r_associated | relid=0 | w=29
  71. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:pregnancy test (urine or serum) not ordered for reasons documented by clinician
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:pregnancy test (urine or serum) not ordered for reasons documented by clinician | rel=r_associated | relid=0 | w=29
  72. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:score on the swallowing functional communication measure at discharge was higher than at admission
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:score on the swallowing functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=29
  73. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v])
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) | rel=r_associated | relid=0 | w=29
  74. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:suicide risk not assessed at the initial evaluation, reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:suicide risk not assessed at the initial evaluation, reason not given | rel=r_associated | relid=0 | w=29
  75. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:three-mutation brca1 and brca2 analysis for susceptibility to breast and ovarian cancer in ashkenazi individuals
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:three-mutation brca1 and brca2 analysis for susceptibility to breast and ovarian cancer in ashkenazi individuals | rel=r_associated | relid=0 | w=29
  76. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; each additional vessel
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; each additional vessel | rel=r_associated | relid=0 | w=29
  77. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:vacuum drainage bottle and tubing for use with implanted catheter
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:vacuum drainage bottle and tubing for use with implanted catheter | rel=r_associated | relid=0 | w=29
  78. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 29 / 0.674 -> en:venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission | rel=r_associated | relid=0 | w=29
  79. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:aneurysm minor diameter 5.6-6.0 cm
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:aneurysm minor diameter 5.6-6.0 cm | rel=r_associated | relid=0 | w=28
  80. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed | rel=r_associated | relid=0 | w=28
  81. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:antiplatelet medication contraindicated
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:antiplatelet medication contraindicated | rel=r_associated | relid=0 | w=28
  82. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:assessed level of activity and symptoms
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:assessed level of activity and symptoms | rel=r_associated | relid=0 | w=28
  83. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:complete gene sequence analysis; brca2 gene
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:complete gene sequence analysis; brca2 gene | rel=r_associated | relid=0 | w=28
  84. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:documentation of diagnosis of chronic kidney disease
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:documentation of diagnosis of chronic kidney disease | rel=r_associated | relid=0 | w=28
  85. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy | rel=r_associated | relid=0 | w=28
  86. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:fluocinolone acetonide, intravitreal implant
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:fluocinolone acetonide, intravitreal implant | rel=r_associated | relid=0 | w=28
  87. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:injection, alemtuzumab, 10 mg administered
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, alemtuzumab, 10 mg administered | rel=r_associated | relid=0 | w=28
  88. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:injection, brentuximab vedotin, 1 mg
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, brentuximab vedotin, 1 mg | rel=r_associated | relid=0 | w=28
  89. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | rel=r_associated | relid=0 | w=28
  90. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:ldl-c was not performed
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:ldl-c was not performed | rel=r_associated | relid=0 | w=28
  91. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:maternal serum quadruple marker screen including alpha-fetoprotein (afp), estriol, human chorionic gonadotropin (hcg) and inhibin a
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:maternal serum quadruple marker screen including alpha-fetoprotein (afp), estriol, human chorionic gonadotropin (hcg) and inhibin a | rel=r_associated | relid=0 | w=28
  92. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:patient not treated for motor speech disorder
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient not treated for motor speech disorder | rel=r_associated | relid=0 | w=28
  93. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:patient receiving antiviral treatment for hepatitis c documented
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient receiving antiviral treatment for hepatitis c documented | rel=r_associated | relid=0 | w=28
  94. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase | rel=r_associated | relid=0 | w=28
  95. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:patients with a positive hepatitis c antibody test
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patients with a positive hepatitis c antibody test | rel=r_associated | relid=0 | w=28
  96. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | rel=r_associated | relid=0 | w=28
  97. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:score on the writing functional communication measure at discharge was higher than at admission
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:score on the writing functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=28
  98. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:severity of angina assessed according to level of activity
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:severity of angina assessed according to level of activity | rel=r_associated | relid=0 | w=28
  99. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:single-mutation analysis (in individual with a known apc mutation in the family) for susceptibility to familial adenomatous polyposis (fap) and attenuated fap
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:single-mutation analysis (in individual with a known apc mutation in the family) for susceptibility to familial adenomatous polyposis (fap) and attenuated fap | rel=r_associated | relid=0 | w=28
  100. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens | rel=r_associated | relid=0 | w=28
  101. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:technetium tc 99m tilmanocept, diagnostic, up to 0.5 millicuries
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:technetium tc 99m tilmanocept, diagnostic, up to 0.5 millicuries | rel=r_associated | relid=0 | w=28
  102. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:the eligible professional practices in a rural area without sufficient high speed internet access and requests a hardship exemption from the application of the payment adjustment under section 1848(a)(5)(a) of the social security act
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:the eligible professional practices in a rural area without sufficient high speed internet access and requests a hardship exemption from the application of the payment adjustment under section 1848(a)(5)(a) of the social security act | rel=r_associated | relid=0 | w=28
  103. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:the eligible professional practices in an area without sufficient available pharmacies for electronic prescribing and requests a hardship exemption for the application of the payment adjustment under section 1848(a)(5)(a) of the social security act
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:the eligible professional practices in an area without sufficient available pharmacies for electronic prescribing and requests a hardship exemption for the application of the payment adjustment under section 1848(a)(5)(a) of the social security act | rel=r_associated | relid=0 | w=28
  104. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 28 / 0.651 -> en:total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v])
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v]) | rel=r_associated | relid=0 | w=28
  105. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:all quality actions for the applicable measures in the epilepsy measures group have been performed for this patient
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:all quality actions for the applicable measures in the epilepsy measures group have been performed for this patient | rel=r_associated | relid=0 | w=27
  106. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:anti-lipid treatment at discharge
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:anti-lipid treatment at discharge | rel=r_associated | relid=0 | w=27
  107. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:cd4+ cell count or cd4+ cell percentage results documented
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:cd4+ cell count or cd4+ cell percentage results documented | rel=r_associated | relid=0 | w=27
  108. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | rel=r_associated | relid=0 | w=27
  109. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | rel=r_associated | relid=0 | w=27
  110. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:documentation of reason(s) for patient not having greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v])
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:documentation of reason(s) for patient not having greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) | rel=r_associated | relid=0 | w=27
  111. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u. | rel=r_associated | relid=0 | w=27
  112. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:i intend to report the back pain measures group
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:i intend to report the back pain measures group | rel=r_associated | relid=0 | w=27
  113. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | rel=r_associated | relid=0 | w=27
  114. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:injection, factor viii, fc fusion protein, (recombinant), per i.u.
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, factor viii, fc fusion protein, (recombinant), per i.u. | rel=r_associated | relid=0 | w=27
  115. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:injection, ocriplasmin, 0.125 mg
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, ocriplasmin, 0.125 mg | rel=r_associated | relid=0 | w=27
  116. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:injection, peginesatide, 0.1 mg (for esrd on dialysis)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, peginesatide, 0.1 mg (for esrd on dialysis) | rel=r_associated | relid=0 | w=27
  117. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:ldl-c not performed, reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:ldl-c not performed, reason not given | rel=r_associated | relid=0 | w=27
  118. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:oral aspirin or other antithrombotic therapy prescribed
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:oral aspirin or other antithrombotic therapy prescribed | rel=r_associated | relid=0 | w=27
  119. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:oral aspirin or other antithrombotic therapy was not prescribed, reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:oral aspirin or other antithrombotic therapy was not prescribed, reason not given | rel=r_associated | relid=0 | w=27
  120. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:patient not treated for reading disorder
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient not treated for reading disorder | rel=r_associated | relid=0 | w=27
  121. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:patient not treated for spoken language expression disorder
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient not treated for spoken language expression disorder | rel=r_associated | relid=0 | w=27
  122. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:patient treated for swallowing but not scored on the swallowing functional communication measure at admission or at discharge
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient treated for swallowing but not scored on the swallowing functional communication measure at admission or at discharge | rel=r_associated | relid=0 | w=27
  123. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=27
  124. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine | rel=r_associated | relid=0 | w=27
  125. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge | rel=r_associated | relid=0 | w=27
  126. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:score on the reading functional communication measure at discharge was higher than at admission
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:score on the reading functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=27
  127. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea | rel=r_associated | relid=0 | w=27
  128. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> en:volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask) | rel=r_associated | relid=0 | w=27
  129. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 27 / 0.628 -> traitement
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=traitement | rel=r_associated | relid=0 | w=27
  130. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:anticoagulation not ordered for reasons documented by clinician
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:anticoagulation not ordered for reasons documented by clinician | rel=r_associated | relid=0 | w=26
  131. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:anticoagulation was not ordered, reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:anticoagulation was not ordered, reason not given | rel=r_associated | relid=0 | w=26
  132. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:asymptomatic patient with no history of any transient ischemic attack or stroke in any carotid or vertebrobasilar territory
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:asymptomatic patient with no history of any transient ischemic attack or stroke in any carotid or vertebrobasilar territory | rel=r_associated | relid=0 | w=26
  133. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders | rel=r_associated | relid=0 | w=26
  134. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression | rel=r_associated | relid=0 | w=26
  135. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:colonoscopy, flexible, proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:colonoscopy, flexible, proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique | rel=r_associated | relid=0 | w=26
  136. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:complete gene sequence analysis for hemochromatosis genetic testing
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:complete gene sequence analysis for hemochromatosis genetic testing | rel=r_associated | relid=0 | w=26
  137. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:diabetes screening test performed
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:diabetes screening test performed | rel=r_associated | relid=0 | w=26
  138. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes | rel=r_associated | relid=0 | w=26
  139. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | rel=r_associated | relid=0 | w=26
  140. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg) | rel=r_associated | relid=0 | w=26
  141. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:documentation of medical reason(s) for not prescribing oral aspirin or other antthrombotic therapy (e.g., patient documented to be low risk or patient with terminal illness or treatment of hypertension with standard treatment goals is not clinically ap
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:documentation of medical reason(s) for not prescribing oral aspirin or other antthrombotic therapy (e.g., patient documented to be low risk or patient with terminal illness or treatment of hypertension with standard treatment goals is not clinically ap | rel=r_associated | relid=0 | w=26
  142. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | rel=r_associated | relid=0 | w=26
  143. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:grafix prime, per square centimeter
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:grafix prime, per square centimeter | rel=r_associated | relid=0 | w=26
  144. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:laparoscopy, surgical, radiofrequency ablations of uterine fibroid(s), including intraoperative guidance and monitoring, when performed
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:laparoscopy, surgical, radiofrequency ablations of uterine fibroid(s), including intraoperative guidance and monitoring, when performed | rel=r_associated | relid=0 | w=26
  145. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c) | rel=r_associated | relid=0 | w=26
  146. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:patient documentation - angina assessed as present
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient documentation - angina assessed as present | rel=r_associated | relid=0 | w=26
  147. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:patient not receiving maintenance hemodialysis in an outpatient dialysis facility
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient not receiving maintenance hemodialysis in an outpatient dialysis facility | rel=r_associated | relid=0 | w=26
  148. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:patient not treated for memory disorder
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient not treated for memory disorder | rel=r_associated | relid=0 | w=26
  149. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase | rel=r_associated | relid=0 | w=26
  150. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given | rel=r_associated | relid=0 | w=26
  151. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:serum creatinine test not performed, reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:serum creatinine test not performed, reason not given | rel=r_associated | relid=0 | w=26
  152. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:suicide risk assessed at the initial evaluation
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:suicide risk assessed at the initial evaluation | rel=r_associated | relid=0 | w=26
  153. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 26 / 0.605 -> en:transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device | rel=r_associated | relid=0 | w=26
  154. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 25 / 0.581 -> en:counseling for diet and physical activity not performed, reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:counseling for diet and physical activity not performed, reason not given | rel=r_associated | relid=0 | w=25
  155. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 25 / 0.581 -> en:hcpcs level ii preferred terms, obsolete
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:hcpcs level ii preferred terms, obsolete | rel=r_associated | relid=0 | w=25
  156. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 25 / 0.581 -> en:injection, medroxyprogesterone acetate, 50 mg
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, medroxyprogesterone acetate, 50 mg | rel=r_associated | relid=0 | w=25
  157. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 25 / 0.581 -> en:injection, sulfur hexafluoride lipid microsphere, per ml
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, sulfur hexafluoride lipid microsphere, per ml | rel=r_associated | relid=0 | w=25
  158. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 25 / 0.581 -> en:level of activity and symptoms not assessed
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:level of activity and symptoms not assessed | rel=r_associated | relid=0 | w=25
  159. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 25 / 0.581 -> en:patient
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient | rel=r_associated | relid=0 | w=25
  160. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 25 / 0.581 -> en:patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit | rel=r_associated | relid=0 | w=25
  161. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 25 / 0.581 -> en:patient documentation - angina assessed as absent
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient documentation - angina assessed as absent | rel=r_associated | relid=0 | w=25
  162. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 25 / 0.581 -> en:patient encounter was documented using an ehr system that has been certified by an authorized testing and certification body (atcb)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient encounter was documented using an ehr system that has been certified by an authorized testing and certification body (atcb) | rel=r_associated | relid=0 | w=25
  163. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 25 / 0.581 -> en:patient had a medical visit in the last 6 months
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient had a medical visit in the last 6 months | rel=r_associated | relid=0 | w=25
  164. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 25 / 0.581 -> en:pregnancy test (urine or serum) was not ordered, reason not specified
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:pregnancy test (urine or serum) was not ordered, reason not specified | rel=r_associated | relid=0 | w=25
  165. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 25 / 0.581 -> en:score on the reading functional communication measure at discharge was not higher than at admission, reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:score on the reading functional communication measure at discharge was not higher than at admission, reason not given | rel=r_associated | relid=0 | w=25
  166. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 25 / 0.581 -> en:score on the spoken language comprehension functional communication measure at discharge was higher than at admission
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:score on the spoken language comprehension functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=25
  167. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 25 / 0.581 -> en:score on the spoken language expression functional communication measure at discharge was higher than at admission
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:score on the spoken language expression functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=25
  168. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 25 / 0.581 -> en:spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given | rel=r_associated | relid=0 | w=25
  169. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 24 / 0.558 -> en:documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | rel=r_associated | relid=0 | w=24
  170. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 24 / 0.558 -> en:genetic testing for gaucher disease
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:genetic testing for gaucher disease | rel=r_associated | relid=0 | w=24
  171. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 24 / 0.558 -> en:genetic testing, comprehensive cardiac ion channel analysis, for variants in 5 major cardiac ion channel genes for individuals with high index of suspicion for familial long qt syndrome (lqts) or related syndromes
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:genetic testing, comprehensive cardiac ion channel analysis, for variants in 5 major cardiac ion channel genes for individuals with high index of suspicion for familial long qt syndrome (lqts) or related syndromes | rel=r_associated | relid=0 | w=24
  172. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 24 / 0.558 -> en:i intend to report the perioperative care measures group
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:i intend to report the perioperative care measures group | rel=r_associated | relid=0 | w=24
  173. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 24 / 0.558 -> en:left ventricular ejection fraction (lvef) not performed or assessed, reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:left ventricular ejection fraction (lvef) not performed or assessed, reason not given | rel=r_associated | relid=0 | w=24
  174. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 24 / 0.558 -> en:lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason | rel=r_associated | relid=0 | w=24
  175. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 24 / 0.558 -> en:most recent office visit diastolic blood pressure, 80 - 89 mm hg
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:most recent office visit diastolic blood pressure, 80 - 89 mm hg | rel=r_associated | relid=0 | w=24
  176. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 24 / 0.558 -> en:positive airway pressure therapy not prescribed
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:positive airway pressure therapy not prescribed | rel=r_associated | relid=0 | w=24
  177. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 24 / 0.558 -> en:promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | rel=r_associated | relid=0 | w=24
  178. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 24 / 0.558 -> en:score on the attention functional communication measure at discharge was higher than at admission
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:score on the attention functional communication measure at discharge was higher than at admission | rel=r_associated | relid=0 | w=24
  179. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 24 / 0.558 -> en:unlisted procedure, intestine
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:unlisted procedure, intestine | rel=r_associated | relid=0 | w=24
  180. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 23 / 0.535 -> en:complete gene sequence analysis; mlh1 gene
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:complete gene sequence analysis; mlh1 gene | rel=r_associated | relid=0 | w=23
  181. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 23 / 0.535 -> en:documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | rel=r_associated | relid=0 | w=23
  182. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 23 / 0.535 -> en:follow-up cta, duplex, or mra of the abdomen and pelvis performed
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:follow-up cta, duplex, or mra of the abdomen and pelvis performed | rel=r_associated | relid=0 | w=23
  183. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 23 / 0.535 -> en:i intend to report the community-acquired pneumonia (cap) measures group
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:i intend to report the community-acquired pneumonia (cap) measures group | rel=r_associated | relid=0 | w=23
  184. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 23 / 0.535 -> en:immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain | rel=r_associated | relid=0 | w=23
  185. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 23 / 0.535 -> en:lipid profile not performed, reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:lipid profile not performed, reason not given | rel=r_associated | relid=0 | w=23
  186. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 23 / 0.535 -> en:most recent blood pressure under control
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:most recent blood pressure under control | rel=r_associated | relid=0 | w=23
  187. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 23 / 0.535 -> en:pneumocystis jiroveci pneumonia prophlaxis prescribed
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:pneumocystis jiroveci pneumonia prophlaxis prescribed | rel=r_associated | relid=0 | w=23
  188. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 23 / 0.535 -> en:portable oxygen contents, gaseous, 1 month's supply = 1 unit, for cluster headaches, for initial months supply or to replace used contents
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:portable oxygen contents, gaseous, 1 month's supply = 1 unit, for cluster headaches, for initial months supply or to replace used contents | rel=r_associated | relid=0 | w=23
  189. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 23 / 0.535 -> en:pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) | rel=r_associated | relid=0 | w=23
  190. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 23 / 0.535 -> en:single mutation analysis (in individual with a known brca1 or brca2 mutation in the family) for susceptibility to breast and ovarian cancer
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:single mutation analysis (in individual with a known brca1 or brca2 mutation in the family) for susceptibility to breast and ovarian cancer | rel=r_associated | relid=0 | w=23
  191. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 23 / 0.535 -> en:venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given | rel=r_associated | relid=0 | w=23
  192. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 23 / 0.535 -> en:volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) | rel=r_associated | relid=0 | w=23
  193. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 22 / 0.512 -> en:drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter | rel=r_associated | relid=0 | w=22
  194. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 22 / 0.512 -> en:duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record | rel=r_associated | relid=0 | w=22
  195. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 22 / 0.512 -> en:follow-up cta, duplex, or mra of the abdomen and pelvis not performed
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:follow-up cta, duplex, or mra of the abdomen and pelvis not performed | rel=r_associated | relid=0 | w=22
  196. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 22 / 0.512 -> en:influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit | rel=r_associated | relid=0 | w=22
  197. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 22 / 0.512 -> en:injection, doxorubicin hydrochloride, all lipid formulations, 10 mg
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, doxorubicin hydrochloride, all lipid formulations, 10 mg | rel=r_associated | relid=0 | w=22
  198. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 22 / 0.512 -> en:injection, sculptra, 0.1 ml
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, sculptra, 0.1 ml | rel=r_associated | relid=0 | w=22
  199. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 22 / 0.512 -> en:injection, testosterone enanthate, up to 100 mg administered
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, testosterone enanthate, up to 100 mg administered | rel=r_associated | relid=0 | w=22
  200. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 22 / 0.512 -> en:patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery | rel=r_associated | relid=0 | w=22
  201. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 22 / 0.512 -> en:patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | rel=r_associated | relid=0 | w=22
  202. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 22 / 0.512 -> en:prescription(s) generated and transmitted via a qualified erx system
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:prescription(s) generated and transmitted via a qualified erx system | rel=r_associated | relid=0 | w=22
  203. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 22 / 0.512 -> en:prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given | rel=r_associated | relid=0 | w=22
  204. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 22 / 0.512 -> en:score on the swallowing functional communication measure at discharge was not higher than at admission, reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:score on the swallowing functional communication measure at discharge was not higher than at admission, reason not given | rel=r_associated | relid=0 | w=22
  205. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 21 / 0.488 -> en:drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter | rel=r_associated | relid=0 | w=21
  206. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 21 / 0.488 -> en:i intend to report the epilepsy measures group
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:i intend to report the epilepsy measures group | rel=r_associated | relid=0 | w=21
  207. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 21 / 0.488 -> en:i intend to report the hypertension (htn) measures group
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:i intend to report the hypertension (htn) measures group | rel=r_associated | relid=0 | w=21
  208. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 21 / 0.488 -> en:influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok)
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok) | rel=r_associated | relid=0 | w=21
  209. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 21 / 0.488 -> en:injection, ferric carboxymaltose, 1 mg
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, ferric carboxymaltose, 1 mg | rel=r_associated | relid=0 | w=21
  210. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 21 / 0.488 -> en:injection, testosterone cypionate, up to 100 mg
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, testosterone cypionate, up to 100 mg | rel=r_associated | relid=0 | w=21
  211. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 21 / 0.488 -> en:no documentation of disease type, anatomic location, and activity, reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:no documentation of disease type, anatomic location, and activity, reason not given | rel=r_associated | relid=0 | w=21
  212. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 21 / 0.488 -> en:patient treated for reading but not scored on the reading functional communication measure either at admission or at discharge
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient treated for reading but not scored on the reading functional communication measure either at admission or at discharge | rel=r_associated | relid=0 | w=21
  213. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 21 / 0.488 -> en:portable gaseous oxygen system, rental, includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing, for cluster headaches
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:portable gaseous oxygen system, rental, includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing, for cluster headaches | rel=r_associated | relid=0 | w=21
  214. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 21 / 0.488 -> en:rehabilitation services were not ordered, reason not otherwise specified
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:rehabilitation services were not ordered, reason not otherwise specified | rel=r_associated | relid=0 | w=21
  215. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 21 / 0.488 -> en:score on the memory functional communication measure at discharge was not higher than at admission, reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:score on the memory functional communication measure at discharge was not higher than at admission, reason not given | rel=r_associated | relid=0 | w=21
  216. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 21 / 0.488 -> en:urine protein test was not performed, reason not given
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:urine protein test was not performed, reason not given | rel=r_associated | relid=0 | w=21
  217. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 20 / 0.465 -> en:implanted pleural catheter, each
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:implanted pleural catheter, each | rel=r_associated | relid=0 | w=20
  218. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 20 / 0.465 -> en:injection, belinostat, 10 mg
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, belinostat, 10 mg | rel=r_associated | relid=0 | w=20
  219. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 20 / 0.465 -> en:injection, pertuzumab, 10 mg
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:injection, pertuzumab, 10 mg | rel=r_associated | relid=0 | w=20
  220. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 20 / 0.465 -> en:ldl value >= 100
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:ldl value >= 100 | rel=r_associated | relid=0 | w=20
  221. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 20 / 0.465 -> en:most recent systolic blood pressure >= 140 mm hg
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:most recent systolic blood pressure >= 140 mm hg | rel=r_associated | relid=0 | w=20
  222. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase -- r_associated #0: 20 / 0.465 -> en:oncology (breast), mrna analysis of 58 genes using hybrid capture, on formalin-fixed paraffin-embedded (ffpe) tissue, prognostic algorithm reported as a risk score
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:oncology (breast), mrna analysis of 58 genes using hybrid capture, on formalin-fixed paraffin-embedded (ffpe) tissue, prognostic algorithm reported as a risk score | rel=r_associated | relid=0 | w=20
≈ 221 relations entrantes

  1. en:abdominal aortic aneurysm is not infarenal --- r_associated #0: 42 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:abdominal aortic aneurysm is not infarenal | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=42
  2. en:genetic testing for canavan disease --- r_associated #0: 42 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:genetic testing for canavan disease | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=42
  3. en:pneumocystis jiroveci pneumonia prophlaxis prescribed --- r_associated #0: 42 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:pneumocystis jiroveci pneumonia prophlaxis prescribed | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=42
  4. en:patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days --- r_associated #0: 41 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=41
  5. en:corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet --- r_associated #0: 40 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=40
  6. en:implanted pleural catheter, each --- r_associated #0: 40 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:implanted pleural catheter, each | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=40
  7. en:portable gaseous oxygen system, rental, includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing, for cluster headaches --- r_associated #0: 40 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:portable gaseous oxygen system, rental, includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing, for cluster headaches | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=40
  8. en:colonoscopy, flexible, proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique --- r_associated #0: 39 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:colonoscopy, flexible, proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=39
  9. en:netupitant 300 mg and palonosetron 0.5 mg --- r_associated #0: 39 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:netupitant 300 mg and palonosetron 0.5 mg | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=39
  10. en:score on the swallowing functional communication measure at discharge was not higher than at admission, reason not given --- r_associated #0: 39 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:score on the swallowing functional communication measure at discharge was not higher than at admission, reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=39
  11. en:beta-blocker at discharge --- r_associated #0: 38 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:beta-blocker at discharge | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=38
  12. en:patient had a medical visit in the last 6 months --- r_associated #0: 38 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient had a medical visit in the last 6 months | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=38
  13. en:promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen --- r_associated #0: 38 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=38
  14. en:score on the reading functional communication measure at discharge was not higher than at admission, reason not given --- r_associated #0: 38 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:score on the reading functional communication measure at discharge was not higher than at admission, reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=38
  15. en:drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter --- r_associated #0: 37 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=37
  16. en:injection, asparaginase erwinia chrysanthemi, 1,000 international units (i.u.) --- r_associated #0: 37 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, asparaginase erwinia chrysanthemi, 1,000 international units (i.u.) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=37
  17. en:injection, brentuximab vedotin, 1 mg --- r_associated #0: 37 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, brentuximab vedotin, 1 mg | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=37
  18. en:antiplatelet medication contraindicated --- r_associated #0: 36 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:antiplatelet medication contraindicated | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=36
  19. en:complete apc gene sequence analysis for susceptibility to familial adenomatous polyposis (fap) and attenuated fap --- r_associated #0: 36 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:complete apc gene sequence analysis for susceptibility to familial adenomatous polyposis (fap) and attenuated fap | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=36
  20. en:complete brca1 and brca2 gene sequence analysis for susceptibility to breast and ovarian cancer --- r_associated #0: 36 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:complete brca1 and brca2 gene sequence analysis for susceptibility to breast and ovarian cancer | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=36
  21. en:documentation of diagnosis of chronic kidney disease --- r_associated #0: 36 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:documentation of diagnosis of chronic kidney disease | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=36
  22. en:influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit --- r_associated #0: 36 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=36
  23. en:injection, epoetin alfa, 1000 units (for esrd on dialysis) administered --- r_associated #0: 36 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, epoetin alfa, 1000 units (for esrd on dialysis) administered | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=36
  24. en:injection, human fibrinogen concentrate, 100 mg --- r_associated #0: 36 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, human fibrinogen concentrate, 100 mg | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=36
  25. en:laparoscopy, surgical, radiofrequency ablations of uterine fibroid(s), including intraoperative guidance and monitoring, when performed --- r_associated #0: 36 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:laparoscopy, surgical, radiofrequency ablations of uterine fibroid(s), including intraoperative guidance and monitoring, when performed | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=36
  26. en:lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c) --- r_associated #0: 36 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=36
  27. en:patient not treated for memory disorder --- r_associated #0: 36 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient not treated for memory disorder | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=36
  28. en:patient not treated for reading disorder --- r_associated #0: 36 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient not treated for reading disorder | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=36
  29. en:patients with a positive hepatitis c antibody test --- r_associated #0: 36 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patients with a positive hepatitis c antibody test | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=36
  30. en:score on the attention functional communication measure at discharge was higher than at admission --- r_associated #0: 36 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:score on the attention functional communication measure at discharge was higher than at admission | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=36
  31. en:single mutation analysis (in individual with a known brca1 or brca2 mutation in the family) for susceptibility to breast and ovarian cancer --- r_associated #0: 36 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:single mutation analysis (in individual with a known brca1 or brca2 mutation in the family) for susceptibility to breast and ovarian cancer | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=36
  32. en:transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device --- r_associated #0: 36 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=36
  33. en:ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  34. en:fluocinolone acetonide, intravitreal implant --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:fluocinolone acetonide, intravitreal implant | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  35. en:grafix prime, per square centimeter --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:grafix prime, per square centimeter | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  36. en:i intend to report the community-acquired pneumonia (cap) measures group --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:i intend to report the community-acquired pneumonia (cap) measures group | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  37. en:i intend to report the hypertension (htn) measures group --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:i intend to report the hypertension (htn) measures group | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  38. en:injection, medroxyprogesterone acetate, 50 mg --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, medroxyprogesterone acetate, 50 mg | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  39. en:injection, peginesatide, 0.1 mg (for esrd on dialysis) --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, peginesatide, 0.1 mg (for esrd on dialysis) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  40. en:injection, testosterone cypionate, up to 100 mg --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, testosterone cypionate, up to 100 mg | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  41. en:injection, testosterone enanthate, up to 100 mg administered --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, testosterone enanthate, up to 100 mg administered | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  42. en:left ventricular ejection fraction (lvef) not performed or assessed, reason not given --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:left ventricular ejection fraction (lvef) not performed or assessed, reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  43. en:maternal serum quadruple marker screen including alpha-fetoprotein (afp), estriol, human chorionic gonadotropin (hcg) and inhibin a --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:maternal serum quadruple marker screen including alpha-fetoprotein (afp), estriol, human chorionic gonadotropin (hcg) and inhibin a | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  44. en:oncology (breast), mrna analysis of 58 genes using hybrid capture, on formalin-fixed paraffin-embedded (ffpe) tissue, prognostic algorithm reported as a risk score --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:oncology (breast), mrna analysis of 58 genes using hybrid capture, on formalin-fixed paraffin-embedded (ffpe) tissue, prognostic algorithm reported as a risk score | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  45. en:patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  46. en:patient treated for swallowing but not scored on the swallowing functional communication measure at admission or at discharge --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient treated for swallowing but not scored on the swallowing functional communication measure at admission or at discharge | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  47. en:positive airway pressure therapy not prescribed --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:positive airway pressure therapy not prescribed | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  48. en:prescription(s) generated and transmitted via a qualified erx system --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:prescription(s) generated and transmitted via a qualified erx system | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  49. en:score on the memory functional communication measure at discharge was not higher than at admission, reason not given --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:score on the memory functional communication measure at discharge was not higher than at admission, reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  50. en:score on the motor speech functional communication measure at discharge was higher than at admission --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:score on the motor speech functional communication measure at discharge was higher than at admission | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  51. en:spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  52. en:technetium tc 99m tilmanocept, diagnostic, up to 0.5 millicuries --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:technetium tc 99m tilmanocept, diagnostic, up to 0.5 millicuries | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  53. en:three-mutation brca1 and brca2 analysis for susceptibility to breast and ovarian cancer in ashkenazi individuals --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:three-mutation brca1 and brca2 analysis for susceptibility to breast and ovarian cancer in ashkenazi individuals | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  54. en:unlisted procedure, intestine --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:unlisted procedure, intestine | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  55. en:volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask) --- r_associated #0: 35 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=35
  56. en:all quality actions for the applicable measures in the epilepsy measures group have been performed for this patient --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:all quality actions for the applicable measures in the epilepsy measures group have been performed for this patient | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  57. en:counseling for diet and physical activity performed --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:counseling for diet and physical activity performed | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  58. en:documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg) --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  59. en:follow-up cta, duplex, or mra of the abdomen and pelvis not performed --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:follow-up cta, duplex, or mra of the abdomen and pelvis not performed | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  60. en:i intend to report the perioperative care measures group --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:i intend to report the perioperative care measures group | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  61. en:injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  62. en:injection, ferric carboxymaltose, 1 mg --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, ferric carboxymaltose, 1 mg | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  63. en:injection, morphine sulfate, 100mg --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, morphine sulfate, 100mg | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  64. en:injection, sulfur hexafluoride lipid microsphere, per ml --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, sulfur hexafluoride lipid microsphere, per ml | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  65. en:injection, ziv-aflibercept, 1 mg --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, ziv-aflibercept, 1 mg | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  66. en:level of activity and symptoms not assessed --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:level of activity and symptoms not assessed | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  67. en:patient encounter was documented using an ehr system that has been certified by an authorized testing and certification body (atcb) --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient encounter was documented using an ehr system that has been certified by an authorized testing and certification body (atcb) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  68. en:patient not receiving maintenance hemodialysis in an outpatient dialysis facility --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient not receiving maintenance hemodialysis in an outpatient dialysis facility | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  69. en:patient not treated for spoken language expression disorder --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient not treated for spoken language expression disorder | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  70. en:patient receiving antiviral treatment for hepatitis c documented --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient receiving antiviral treatment for hepatitis c documented | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  71. en:patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  72. en:pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  73. en:prednisone, oral, per 5 mg --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:prednisone, oral, per 5 mg | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  74. en:prostate cancer antigen 3 (pca3) testing --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:prostate cancer antigen 3 (pca3) testing | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  75. en:the eligible professional practices in a rural area without sufficient high speed internet access and requests a hardship exemption from the application of the payment adjustment under section 1848(a)(5)(a) of the social security act --- r_associated #0: 34 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:the eligible professional practices in a rural area without sufficient high speed internet access and requests a hardship exemption from the application of the payment adjustment under section 1848(a)(5)(a) of the social security act | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=34
  76. en:anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  77. en:complete gene sequence analysis; mlh1 gene --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:complete gene sequence analysis; mlh1 gene | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  78. en:counseling for diet and physical activity not performed, reason not given --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:counseling for diet and physical activity not performed, reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  79. en:documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  80. en:follow-up cta, duplex, or mra of the abdomen and pelvis performed --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:follow-up cta, duplex, or mra of the abdomen and pelvis performed | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  81. en:i intend to report the back pain measures group --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:i intend to report the back pain measures group | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  82. en:immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  83. en:influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok) --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  84. en:injection, testosterone enanthate, up to 200 mg administered --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, testosterone enanthate, up to 200 mg administered | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  85. en:laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band) --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  86. en:ldl-c not performed, reason not given --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:ldl-c not performed, reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  87. en:oral aspirin or other antithrombotic therapy was not prescribed, reason not given --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:oral aspirin or other antithrombotic therapy was not prescribed, reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  88. en:patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  89. en:patient not treated for motor speech disorder --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient not treated for motor speech disorder | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  90. en:patient treated for spoken language expression but not scored on the spoken language expression functional communication measure either at admission or at discharge --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient treated for spoken language expression but not scored on the spoken language expression functional communication measure either at admission or at discharge | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  91. en:score on the writing functional communication measure at discharge was higher than at admission --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:score on the writing functional communication measure at discharge was higher than at admission | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  92. en:spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  93. en:surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  94. en:venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission --- r_associated #0: 32 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=32
  95. en:clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  96. en:congestive heart failure telemonitoring, equipment rental, including telescale, computer system and software, telephone connections, and maintenance, per month --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:congestive heart failure telemonitoring, equipment rental, including telescale, computer system and software, telephone connections, and maintenance, per month | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  97. en:factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u. --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u. | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  98. en:injection, alemtuzumab, 10 mg administered --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, alemtuzumab, 10 mg administered | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  99. en:injection, taliglucerase alfa, 10 units --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, taliglucerase alfa, 10 units | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  100. en:lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  101. en:miscellaneous supply or accessory for use with ventricular assist device --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:miscellaneous supply or accessory for use with ventricular assist device | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  102. en:most recent blood pressure under control --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:most recent blood pressure under control | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  103. en:most recent ldl-c under control, results documented and reviewed --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:most recent ldl-c under control, results documented and reviewed | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  104. en:most recent office visit diastolic blood pressure, 80 - 89 mm hg --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:most recent office visit diastolic blood pressure, 80 - 89 mm hg | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  105. en:no anti-lipid treatment at discharge --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:no anti-lipid treatment at discharge | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  106. en:patient documentation - angina assessed as present --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient documentation - angina assessed as present | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  107. en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  108. en:pregnancy test (urine or serum) was not ordered, reason not specified --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:pregnancy test (urine or serum) was not ordered, reason not specified | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  109. en:score on the swallowing functional communication measure at discharge was higher than at admission --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:score on the swallowing functional communication measure at discharge was higher than at admission | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  110. en:serum creatinine test not performed, reason not given --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:serum creatinine test not performed, reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  111. en:severity of angina assessed according to level of activity --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:severity of angina assessed according to level of activity | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  112. en:single-mutation analysis (in individual with a known apc mutation in the family) for susceptibility to familial adenomatous polyposis (fap) and attenuated fap --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:single-mutation analysis (in individual with a known apc mutation in the family) for susceptibility to familial adenomatous polyposis (fap) and attenuated fap | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  113. en:symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea --- r_associated #0: 31 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=31
  114. en:documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) --- r_associated #0: 30 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=30
  115. en:documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required) --- r_associated #0: 30 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=30
  116. en:duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record --- r_associated #0: 30 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=30
  117. en:electronic wrist rotator, otto bock or equal --- r_associated #0: 30 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:electronic wrist rotator, otto bock or equal | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=30
  118. en:injection, belinostat, 10 mg --- r_associated #0: 30 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, belinostat, 10 mg | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=30
  119. en:injection, doxorubicin hydrochloride, all lipid formulations, 10 mg --- r_associated #0: 30 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, doxorubicin hydrochloride, all lipid formulations, 10 mg | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=30
  120. en:injection, factor viii, fc fusion protein, (recombinant), per i.u. --- r_associated #0: 30 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, factor viii, fc fusion protein, (recombinant), per i.u. | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=30
  121. en:ldl-c was not performed --- r_associated #0: 30 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:ldl-c was not performed | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=30
  122. en:levonorgestrel 52mg intrauterine system --- r_associated #0: 30 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:levonorgestrel 52mg intrauterine system | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=30
  123. en:oral aspirin or other antithrombotic therapy prescribed --- r_associated #0: 30 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:oral aspirin or other antithrombotic therapy prescribed | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=30
  124. en:patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days --- r_associated #0: 30 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=30
  125. en:prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given --- r_associated #0: 30 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=30
  126. en:volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) --- r_associated #0: 30 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=30
  127. en:documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  128. en:documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  129. en:dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  130. en:endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  131. en:factor ix (antihemophilic factor, recombinant), rixubis, per i.u. --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:factor ix (antihemophilic factor, recombinant), rixubis, per i.u. | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  132. en:genetic testing, comprehensive cardiac ion channel analysis, for variants in 5 major cardiac ion channel genes for individuals with high index of suspicion for familial long qt syndrome (lqts) or related syndromes --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:genetic testing, comprehensive cardiac ion channel analysis, for variants in 5 major cardiac ion channel genes for individuals with high index of suspicion for familial long qt syndrome (lqts) or related syndromes | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  133. en:hcpcs level ii preferred terms, obsolete --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:hcpcs level ii preferred terms, obsolete | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  134. en:injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  135. en:injection, zoledronic acid (zometa), 1 mg administered --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, zoledronic acid (zometa), 1 mg administered | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  136. en:lipid profile not performed, reason not given --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:lipid profile not performed, reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  137. en:most recent ldl-c not under control, results documented and reviewed --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:most recent ldl-c not under control, results documented and reviewed | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  138. en:patch closure used for patient undergoing conventional cea --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patch closure used for patient undergoing conventional cea | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  139. en:patient documentation - angina assessed as absent --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient documentation - angina assessed as absent | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  140. en:patient treated for reading but not scored on the reading functional communication measure either at admission or at discharge --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient treated for reading but not scored on the reading functional communication measure either at admission or at discharge | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  141. en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  142. en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  143. en:pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  144. en:portable oxygen contents, gaseous, 1 month's supply = 1 unit, for cluster headaches, for initial months supply or to replace used contents --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:portable oxygen contents, gaseous, 1 month's supply = 1 unit, for cluster headaches, for initial months supply or to replace used contents | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  145. en:pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  146. en:score on the reading functional communication measure at discharge was higher than at admission --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:score on the reading functional communication measure at discharge was higher than at admission | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  147. en:suicide risk not assessed at the initial evaluation, reason not given --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:suicide risk not assessed at the initial evaluation, reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  148. en:total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v]) --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v]) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  149. en:vacuum drainage bottle and tubing for use with implanted catheter --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:vacuum drainage bottle and tubing for use with implanted catheter | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  150. en:venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given --- r_associated #0: 29 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=29
  151. en:colonoscopy through stoma; with transendoscopic stent placement (includes predilation) --- r_associated #0: 28 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:colonoscopy through stoma; with transendoscopic stent placement (includes predilation) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=28
  152. en:compounded drug, not otherwise classified --- r_associated #0: 28 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:compounded drug, not otherwise classified | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=28
  153. en:diabetes screening test not performed, reason not given --- r_associated #0: 28 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:diabetes screening test not performed, reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=28
  154. en:direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes --- r_associated #0: 28 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=28
  155. en:drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter --- r_associated #0: 28 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=28
  156. en:i intend to report the epilepsy measures group --- r_associated #0: 28 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:i intend to report the epilepsy measures group | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=28
  157. en:injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) --- r_associated #0: 28 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=28
  158. en:injection, ocriplasmin, 0.125 mg --- r_associated #0: 28 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, ocriplasmin, 0.125 mg | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=28
  159. en:injection, pertuzumab, 10 mg --- r_associated #0: 28 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, pertuzumab, 10 mg | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=28
  160. en:injection, sculptra, 0.1 ml --- r_associated #0: 28 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:injection, sculptra, 0.1 ml | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=28
  161. en:ldl value >= 100 --- r_associated #0: 28 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:ldl value >= 100 | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=28
  162. en:no documentation of disease type, anatomic location, and activity, reason not given --- r_associated #0: 28 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:no documentation of disease type, anatomic location, and activity, reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=28
  163. en:patient not treated for attention disorder --- r_associated #0: 28 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:patient not treated for attention disorder | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=28
  164. en:score on the spoken language comprehension functional communication measure at discharge was higher than at admission --- r_associated #0: 28 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:score on the spoken language comprehension functional communication measure at discharge was higher than at admission | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=28
  165. en:score on the spoken language expression functional communication measure at discharge was higher than at admission --- r_associated #0: 28 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:score on the spoken language expression functional communication measure at discharge was higher than at admission | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=28
  166. en:urine protein test was not performed, reason not given --- r_associated #0: 28 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:urine protein test was not performed, reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=28
  167. en:anti-lipid treatment at discharge --- r_associated #0: 27 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:anti-lipid treatment at discharge | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=27
  168. en:assessed level of activity and symptoms --- r_associated #0: 27 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:assessed level of activity and symptoms | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=27
  169. en:documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for for whom treatment of hypertension with standard treatment goals is not clinically appropriate) --- r_associated #0: 27 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=27
  170. en:documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) --- r_associated #0: 27 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=27
  171. en:documentation of reason(s) for patient not having greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) --- r_associated #0: 27 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:documentation of reason(s) for patient not having greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=27
  172. en:genetic testing for gaucher disease --- r_associated #0: 27 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:genetic testing for gaucher disease | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=27
  173. en:most recent systolic blood pressure >= 140 mm hg --- r_associated #0: 27 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:most recent systolic blood pressure >= 140 mm hg | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=27
  174. en:pregnancy test (urine or serum) not ordered for reasons documented by clinician --- r_associated #0: 27 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:pregnancy test (urine or serum) not ordered for reasons documented by clinician | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=27
  175. en:prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen --- r_associated #0: 27 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=27
  176. en:rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge --- r_associated #0: 27 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=27
  177. en:rehabilitation services were not ordered, reason not otherwise specified --- r_associated #0: 27 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:rehabilitation services were not ordered, reason not otherwise specified | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=27
  178. en:suicide risk assessed at the initial evaluation --- r_associated #0: 27 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:suicide risk assessed at the initial evaluation | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=27
  179. en:the eligible professional practices in an area without sufficient available pharmacies for electronic prescribing and requests a hardship exemption for the application of the payment adjustment under section 1848(a)(5)(a) of the social security act --- r_associated #0: 27 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:the eligible professional practices in an area without sufficient available pharmacies for electronic prescribing and requests a hardship exemption for the application of the payment adjustment under section 1848(a)(5)(a) of the social security act | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=27
  180. en:transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; each additional vessel --- r_associated #0: 27 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; each additional vessel | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=27
  181. en:aneurysm minor diameter <= 5.5 cm for men --- r_associated #0: 21 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:aneurysm minor diameter <= 5.5 cm for men | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=21
  182. en:12-lead electrocardiogram (ecg) performed --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:12-lead electrocardiogram (ecg) performed | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  183. en:adenoma(s) or other neoplasm not detected during screening colonoscopy --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:adenoma(s) or other neoplasm not detected during screening colonoscopy | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  184. en:all quality actions for the applicable measures in the cardiovascular prevention measures group have bee performed for this patient --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:all quality actions for the applicable measures in the cardiovascular prevention measures group have bee performed for this patient | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  185. en:all quality actions for the applicable measures in the ischemic vascular disease (ivd) measures group have been performed for this patient --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:all quality actions for the applicable measures in the ischemic vascular disease (ivd) measures group have been performed for this patient | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  186. en:aneurysm minor diameter 5.6-6.0 cm --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:aneurysm minor diameter 5.6-6.0 cm | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  187. en:aneurysm minor diameter 5.6-6.0 cm for women --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:aneurysm minor diameter 5.6-6.0 cm for women | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  188. en:aneurysm minor diameter <= 6 cm for men --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:aneurysm minor diameter <= 6 cm for men | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  189. en:aneurysm minor diameter >6cm for women --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:aneurysm minor diameter >6cm for women | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  190. en:angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed for patients with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic fun --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed for patients with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic fun | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  191. en:ankle orthosis, ankle gauntlet or similar, with or without joints, custom a fabricated --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:ankle orthosis, ankle gauntlet or similar, with or without joints, custom a fabricated | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  192. en:anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies) --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  193. en:anticoagulation not ordered for reasons documented by clinician --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:anticoagulation not ordered for reasons documented by clinician | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  194. en:anticoagulation was not ordered, reason not given --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:anticoagulation was not ordered, reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  195. en:assessment of depression severity at the initial evaluation --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:assessment of depression severity at the initial evaluation | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  196. en:asymptomatic patient with no history of any transient ischemic attack or stroke in any carotid or vertebrobasilar territory --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:asymptomatic patient with no history of any transient ischemic attack or stroke in any carotid or vertebrobasilar territory | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  197. en:automated eeg monitoring --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:automated eeg monitoring | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  198. en:beta blocker contraindicated --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:beta blocker contraindicated | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  199. en:brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  200. en:cd4+ cell count or cd4+ cell percentage results documented --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:cd4+ cell count or cd4+ cell percentage results documented | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  201. en:chlorpromazine hydrochloride, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:chlorpromazine hydrochloride, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  202. en:circulating tumor cell test --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:circulating tumor cell test | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  203. en:clinician documented that patient is not an eligible candidate for counseling regarding contraception prior to antiviral treatment; patient not receiving antiviral treatment for hepatitis c --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:clinician documented that patient is not an eligible candidate for counseling regarding contraception prior to antiviral treatment; patient not receiving antiviral treatment for hepatitis c | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  204. en:clinician documented that patient recevied vascular access other than autogenous av fistula, reason not given --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:clinician documented that patient recevied vascular access other than autogenous av fistula, reason not given | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  205. en:clinician documented that patient was not an eligible candidate for autogenous av fistula --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:clinician documented that patient was not an eligible candidate for autogenous av fistula | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  206. en:clinician documented that patient was not an eligible candidate for ordering prophylactic parenteral antibiotics to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incisio --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:clinician documented that patient was not an eligible candidate for ordering prophylactic parenteral antibiotics to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incisio | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  207. en:clinician documented that patient with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function was not an eligible candidate for angiotensin converting enzyme (ace) inhibi --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:clinician documented that patient with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function was not an eligible candidate for angiotensin converting enzyme (ace) inhibi | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  208. en:colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  209. en:complete and appropriate patient data were reported to a qualified clinical database registry --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:complete and appropriate patient data were reported to a qualified clinical database registry | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  210. en:complete gene sequence analysis for hemochromatosis genetic testing --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:complete gene sequence analysis for hemochromatosis genetic testing | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  211. en:complete gene sequence analysis; brca2 gene --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:complete gene sequence analysis; brca2 gene | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  212. en:complete gene sequence analysis; msh2 gene --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:complete gene sequence analysis; msh2 gene | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  213. en:death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement period --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement period | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  214. en:diabetes screening test performed --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:diabetes screening test performed | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  215. en:dna analysis of the f5 gene for susceptibility to factor v leiden thrombophilia --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:dna analysis of the f5 gene for susceptibility to factor v leiden thrombophilia | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  216. en:documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation) --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  217. en:documentation of medical reason(s) for not performing serum creatinine test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:documentation of medical reason(s) for not performing serum creatinine test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  218. en:documentation of medical reason(s) for not prescribing oral aspirin or other antthrombotic therapy (e.g., patient documented to be low risk or patient with terminal illness or treatment of hypertension with standard treatment goals is not clinically ap --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:documentation of medical reason(s) for not prescribing oral aspirin or other antthrombotic therapy (e.g., patient documented to be low risk or patient with terminal illness or treatment of hypertension with standard treatment goals is not clinically ap | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  219. en:documentation of patient reason(s) for not being able to assess (e.g., patient refuses endoscopic and/or radiologic assessment) --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:documentation of patient reason(s) for not being able to assess (e.g., patient refuses endoscopic and/or radiologic assessment) | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  220. en:documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e.g., patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make th --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=en:documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e.g., patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make th | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
  221. traitement --- r_associated #0: 20 --> en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
    n1=traitement | n2=en:patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase | rel=r_associated | relid=0 | w=20
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr